Top 20 Life Science VC Funds & Investors in Oceania (June 2026)

Portfolio highlights

• Q-CTRL — Infrastructure software to power the quantum future
• Swoop Aero — Transforming how the world moves by making access to the skies seamless. Kite Aero is the only end-to-end drone logistics platform on the planet. We unlock the potential of the sky, for the good of us all. Currently we serve over 4.5 million people in 6 continents. By 2030, our reach will extend to 1 billion.
• Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com

Portfolio highlights

• BioLumic — BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013.
• Agteria Biotech — Agteria Biotech is an innovative biotech startup dedicated to mitigating methane emissions in cattle through our groundbreaking compound. By promoting sustainable practices in livestock farming, we aim to engage investors and dairy companies interested in eco-friendly solutions. Partner with us to t
• Ruminant BioTech — Ruminant BioTech is a company that creates slow-release devices for long-term controlled-release methane mitigation.

Portfolio highlights

• i14 — We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round.
• Mirugen — Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.
• Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.

Portfolio highlights

• Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.

Portfolio highlights

• Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.

Portfolio highlights

• LCG Capital Management — LCG Capital Management delivers expert real estate solutions, from property management in St. Louis, MO, to asset management & development.

Portfolio highlights

• Digestiva — We amplifye Protein.
• EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
• Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.

Portfolio highlights

• EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
• VSPARTICLE — VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, healthcare, additive manufacturing, nano safety, and more. It also enables research and industry to generate new materials at the push of a button.They specialize in nanoparticle production and integration. The technologyspeeds up the developments of customers by producing the desired nanoparticles on location and integrate them directly in the final product. VSPARTICLE was founded in 2014 and is headquartered in Delft, The Netherlands.
• Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit

Portfolio highlights

• Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
• Mosaic Dental Collective — Mosaic Dental Collective provides administrative and business operations support to dental practices. They are a multi-specialty group where doctors make decisions and are supported by an experienced professional management team.
• Heartland Veterinary Partners — Heartland Veterinary Partners purchases practices, providing operational support for payroll, HR, marketing, and more. Veterinarians can focus on patient care.

Portfolio highlights

• Neuromersiv — Combining Virtual Reality, haptics and functional electrical stimulation, Neuromersiv is revolutionising brain rehabilitation therapy.Using a proprietary wearable device paired with a VR headset, Neuromersiv provides an engaging, immersive therapy experience in which patients perform gamified tasks ranging from picking up a toothbrush to climbingEverest! This unique approach increases dopamine activity in the brain, enhancing neuroplasticity, which is the brain’s ability to form new neural connections. Early trials of Neuromersiv technology have demonstrated 3x better outcomes as compared to traditional rehabilitation therapy resulting in faster independence and reduced care costs.
• Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).

Portfolio highlights

• BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
• Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
• Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com

Portfolio highlights

• Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
• Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
• DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.

Portfolio highlights

• TALY — TALY is a platform that is designed to find, manage and retain employees from both perfromance and personality for business development.
• Termina — Termina operates as an energy tech startup.
• BarterAds Pty Ltd — BarterAds is a programmatic advertising exchange that enables businesses to acquire customers without cash spend by converting unused ad inventory into a tradable asset. Instead of paying in fiat, companies earn and spend a proprietary internal currency called Barter Dollars, which are issued when they display ads on their owned media propertiessuch as websites, apps, or platforms.The platform operates as an auction-based exchange, similar to traditional ad networks, where advertisers bid for impressions using Barter Dollars. Inventory is matched contextually and priced dynamically through real-time bidding, ensuring efficient allocation of supply and demand across the network. This allows both advertisers and publishers to maximize the value of otherwise underutilized inventory.BarterAds primarily targets startups, SaaS platforms, marketplaces, gaming companies, and content publishers that have traffic but are constrained by rising customer acquisition costs. By removing the need for upfront cash spend, the platform provides a capital-efficient growth channel, particularly for small and mid-sized businesses.The system includes controls for brand safety, fraud prevention, and inventory quality through business verification, campaign approvals, and continuous monitoring. Barter Dollars are non-transferable and expire periodically, preventing hoarding and ensuring continuous circulation within the ecosystem.BarterAds is designed as a hybrid between barter networks and modern ad exchanges, combining the scalability and automation of programmatic advertising with a closed-loop, cashless economy. The company is headquartered in Australia and is focused on building a global network of advertisers and publishers who both contribute inventory and run campaigns within the platform.

Portfolio highlights

• World View Enterprises — World View sets the standard for stratospheric exploration via remote sensing, C4ISR and asset monitoring via stratospheric balloons, along with future space tourism and research and education offerings.
• RayGen — We're powering the future with low cost, high efficiency solar power technology and renewable energy storage. Contact us for more details today.
• Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).

Portfolio highlights

• Hatchtech — Hatchtech is an Australian company developing a locally developed proprietary technology platform that will enable the creation of a new generation of lowtoxicity pest control products. Specifically, the patented technology allows the complete blocking of pest species egg hatch through a novel mode of action. The technology has applicability forcontrolling ectoparasites and other egg laying pests of humans, animal, crops and the built environment.
• Lucia Bio — Lucia Bio is a biotechnology company that focuses on developing Syk inhibitors that help in the treatment of immunological diseases.
• Certa Therapeutics — Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.

Portfolio highlights

• Beforepay — Beforepay understands that traditional pay cycles are a form of financial stress. So we set out to find a better way, giving Australians the control and confidence that comes with managing your own money, on your terms.That’s why we created Pay On Demand™ - a service that allows you to access the money you have earned at work, when you choose todo so. After all, it is yours!The app also automatically predicts when your bills are due, shows you how much is OK for you to spend, and automatically creates budgets for you, effortlessly.
• Academy Xi — At Academy Xi, we help APAC's largest and most sophisticated organisations optimise performance with concise, actionable training solutions.
• DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!

Portfolio highlights

• Avava — Avava is a Pioneer precision skin therapy to improve the quality of life for patients around the world.
• Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
• Medical Informatics — Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety. The company’s Sickbay software platform enables continuous data collection from a comprehensive set of devices. Ultimately their alarm management solutions reduce alarm noise at the patient level, and send the rightalarms to care providers.Medical Informatics Corp was founded by Emma Fauss and Craig Rusin in 2010 and is based in Houston, Texas.

Portfolio highlights

• LCG Capital Management — LCG Capital Management delivers expert real estate solutions, from property management in St. Louis, MO, to asset management & development.

Portfolio highlights

• Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
• BiVACOR — Replacing Hearts. Restoring Lives. HEART FAILURE Heart Failure (HF) is a devastating disease that affects more than 11 million people in the US and Europe, with an incidence of 1.1 million new cases per year. Furthermore, current growth rates predict a 25% increase in the incidence of HF by
• Hatchtech — Hatchtech is an Australian company developing a locally developed proprietary technology platform that will enable the creation of a new generation of lowtoxicity pest control products. Specifically, the patented technology allows the complete blocking of pest species egg hatch through a novel mode of action. The technology has applicability forcontrolling ectoparasites and other egg laying pests of humans, animal, crops and the built environment.

Portfolio highlights

• Denteric — Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three parts each year from 2019 to 2021.
• Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
• Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.